minnlab_litbot

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results dlvr.it/T4lSrN

TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers dlvr.it/T4lSrL

iNOS is necessary for GBP-mediated T. gondii clearance in murine macrophages via vacuole nitration and intravacuolar network collapse dlvr.it/T4lSrC

Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies dlvr.it/T4lSqr

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study dlvr.it/T4lSpV

Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases dlvr.it/T4lSLP

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories dlvr.it/T4k1zQ

3D live imaging and phenotyping of the subcellular cytotoxicity in cancer immunotherapy using event-triggered Bessel oblique plane microscopy dlvr.it/T4jWkQ

STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy dlvr.it/T4jWhg

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis dlvr.it/T4hn2g

Induction of immortal-like and functional CAR T cells by defined factors dlvr.it/T4frrP

Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity dlvr.it/T4chgD

ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition dlvr.it/T4chdN

RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity dlvr.it/T4cCYh

Conversion of natural cytokine receptors into orthogonal synthetic biosensors dlvr.it/T4ZfyF

Endogenous CD28 drives CAR T cell responses in multiple myeloma dlvr.it/T4Z50F

Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides dlvr.it/T4X6dX

BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3 dlvr.it/T4X6d6

A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility dlvr.it/T4X6cW

Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy dlvr.it/T4WdTZ